Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: A systematic review

British Journal of General Practice

Volumn 60, Issue 575, 2010, Pages

  Gallagher, Hugh ^a   De Lusignan, Simon ^a   Harris, Kevin ^a   Cates, Christopher ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; Chronic; Diabetes mellitus; Evidence based medicine; Health care; Hypertension; Kidney failure; Quality assurance

Indexed keywords

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ETHNICITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; NURSE; OUTCOME ASSESSMENT; PHARMACIST; PRIMARY MEDICAL CARE; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT;

CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 78650447172     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X502164     Document Type: Review

References (41)

1. Gomez GB, de Lusignan S, Gallagher H. Chronic kidney disease: a new priority for primary care. Br J Gen Pract 2006; 56 (533): 908-910. (Pubitemid 44941787)
2. Klebe B, Farmer C, Cooley R, et al. Kidney disease management in UK primary care: guidelines, incentives and information technology. Fam Proct 2007; 24 (4): 330-335. (Pubitemid 47399890)
3. Glynn LG, Buckley B, Reddan D, et al. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J Gen Pract 2008; 58 (552): 488-194.
4. Farrington K, Udayaraj U, Glig J, Feehally J. ESRD incident rates in 2007 in the UK: national and centre-specific analyses In: Renal Registry Report 2008. Bristol: Renal Registry, 2008: 13-41. http:/www.renalreg.com/Report-Area/ Report%202008/Chapter03.pdf (accessed 6 Jan 2010).
5. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43 (5): 825-835.
6. Klebe B, Irving J, Stevens PE, et al. The cost of implementing UK guidelines for the management of chronic kidney disease. Nephrol Dial Transplant 2007; 22 (9): 2504-2512. (Pubitemid 47365513)
7. De Lusignan S, Chan T, Stevens P, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22 (3): 234-241. (Pubitemid 40744499)
8. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41 (1): 1-12.
9. Anandarajah S, Tai T, de Lusignan S, et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrol Dial Transplant 2005; 20 (10): 2089-2096.
10. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 2006; 15 (3): 276-284.
11. Lamb EJ, Tomson CR, Roderick PJ. Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42 (5): 321-345.
12. New J P, Middleton RJ, Klebe B, et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 2007; 24 (4): 364-369.
13. Jones C, Roderick P, Harris S, Rogerson M. An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD. Am J Kidney Dis 2006; 47 (1): 103-114. (Pubitemid 41828272)
14. Department of Health. National service framework for renal services part two: chronic kidney disease, acute renal failure and end of life care. London: Department of Health, 2005. http://www.dh.gov.uk/en/Publicationsandstaristics/ Publications/Publica tionsPolicyAndGuidance/DH-4101902 (accessed 26 Jan 2010).
15. National Institute for Health and Clinical Excellence (NICE), Early identification and management of chronic kidney diease in adults in primary and secondary care. Clinical guideline CG73. London: NICE, 2008. http://guidancc.nice.org.uk/CG73 (accessed 6 Jan 2010).
16. NHS Primary Care Commissioning. Quality and Outcomes Framework. http://www.pcc.nhs.uk/qofhome (accessed 6 Jan 2010).
17. Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72 (1): 92-99.
18. De Lusignan S, Chan T, Gallagher H, et al. Chronic kidney disease management in southeast England: a preliminary cross-sectional report from the QICKD -Quality improvement in chronic kidney disease study. Prim Care Cardiol J 2009; 12 (1): 33-9. http://www.pccj.eu/pdf/3323/Vol2-Num1-April-MayJune-2009- p33-39.pdf?sid=5501246170832c38 (accessed 6 Jan 2010).
19. Walsh JM, McDonald KM, Shojania KG, et al. Quality improvement strategies for hypertension management: a systematic review. Med Care 2006; 44 (7): 646-657.
20. Fahey T, Schroeder K, Ebrahim S, Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract 2005; 55 (520): 875-882.
21. No authors listed. Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979; 242 (23): 2572-2577. (Pubitemid 10170286)
22. No authors listed. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 988; 259 (14): 2113-2122.
23. De Lusignan S, Gallagher H, Chan T, et al. The QICKD study protocol: a cluster randomised trial to compare quality improvement interventions to lower systolic BP in chronic kidney disease (CKD) in primary care. Implement Sci 2009; 4: 39.
24. The Cochrane Effective Practice and Organisation of Care Group (EPOC). http://www.cpoc.cochrane.org/ (accessed 6 Jan 2010).
25. The Cochrane Renal Group. http://www.cochrane-renal.org/ (accessed 6 Jan 2010).
26. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351 (13): 1296-1305.
27. Kalra PA, Mam tora H, Holmes AM, Waldek S. Renovascular disease and renal complications of angiotensin-eonverting enzyme inhibitor therapy. Q J Med 1990; 77 (282): 1013-1018.
28. Landis JR, Gaughan Q Joffe M. Inter-laboratory scrum creatinine (sCr) calibration study. J Am Soc Nephrol 2003; 14: 294A-294A.
29. McGhee SM, Mclnnes GT, Hedley AJ, et al. Coordinating and standardizing long-term care: evaluation of the west of Scotland sharedcare scheme for hypertension. Br J Gen Pract 1994; 44 (387): 441-145.
30. De Berardis G, Pellegrini F, Franciosi M, et al. QuED Study. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 2004; 27 (2): 398-406.
31. So WY, Tong PC Ko GT, et al. Effects of protocol -driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes. Am J Manag Care 2003; 9 (9): 606-615.
32. Hill MN, Han HR, Dennison CR, et al. Hypertension care and control in underserved urban African American men: behavioral and physiologic outcomes at 36 months. Am J Hypertens 2003; 16 (11 Pt 1): 906-913.
33. Dennison CR, Post WS, Kim MT, et al. Underserved urban African American men: hypertension trial outcomes and mortality during 5 years. Am J Hypertens 2007; 20 (2): 164-171.
34. Chisholm MA, Mulloy LL, Jagadeesan M, et al. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002; 12 (3): 392-397.
35. Tobe SW, Pylypchuk G, Wentworth J, et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ 2006; 174 (9): 1267-1271.
36. Meulepas MA, Braspenning JC, de Grauw WJ, et al. Logistic support service improves processes and outcomes of diabetes care in general practice. Fam Pract 2007; 24 (1): 20-25.
37. Binik YM, Devins GM, Barre PE, et al. Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis 1993; 181: 371-376.
38. Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30 (3): 238-243. (Pubitemid 126497295)
39. Mazzuca SA, Moorman NH, Wheeler ML, et al. The diabetes education study: a controlled trial of the effects of diabetes patient education. Diabetes Care 1986; 9 (1): 1-10. (Pubitemid 16122232)
40. New JP, Hollis S, Campbell F, et al. Measuring clinical performance and outcomes from diabetes information systems: an observational study. Diabetologia 2000; 43 (7): 836-843.
41. Richards N, Harris K, Whitfield M, et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant 2008; 23 (2): 549-555.